Search
Showing results for "1"
Research
The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheezeA recently proposed method for classifying preschool wheeze is to describe it as either episodic (viral) wheeze or multiple trigger wheeze.
The Opportunity The Kids Research Institute Australia is looking for a motivated individual who would like to join the Information Communication and
News & Events
Free-living CGM Performance StudyParticipants are needed for a new study that will test the performance of a new Medtronic sensor with readings from finger-pricks.
Research
Life in a time of COVID: retrospective examination of the association between physical activity and mental well-being in western Australians during and after lockdownThe aim of this study was to examine physical activity and sedentary behaviours during Western Australia's COVID-19 lockdown and their association with mental well-being.
Research
Effect of single versus multistrain probiotic in extremely preterm infants: a randomised trialEvidence indicates that multistrain probiotics benefit preterm infants more than single-strain (SS) probiotics. We assessed the effects of SS versus triple-strain (TS) probiotic supplementation (PS) in extremely preterm (EP) infants.
News & Events
Does your school pass the test?Do you feel your child is well supported by their school when it comes to managing diabetes? If so, our researchers want to hear from you.
News & Events
Frangipani Family DayFrangipani Family Day is an opportunity for CliniKids to celebrate the families we engage with through our clinical services and research.
Research
Peptides targeting the mitogen-activated protein kinase pathway (JNK/JUN) fail to reduce infarct volume after permanent MCAO in sprague dawley ratsIn this study we have assessed the ability of two TAT-fused peptides to reduce infarct volume and improve functional outcome following permanent ischaemia.
Research
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.